Objectives: Evaluate the cytotoxicity and genotoxicity of short-and long-term e-cigarette vapor exposure on a panel of normal epithelial and head and neck squamous cell carcinoma (HNSCC) cell lines. Materials and methods: HaCaT, UMSCC10B, and HN30 were treated with nicotine-containing and nicotine-free vapor extract from two popular e-cigarette brands for periods ranging from 48 h to 8 weeks. Cytotoxicity was assessed using Annexin V flow cytometric analysis, trypan blue exclusion, and clonogenic assays. Genotoxicity in the form of DNA strand breaks was quantified using the neutral comet assay and c-H2AX immunostaining.
Introduction
Electronic cigarettes, or e-cigs, are battery-operated devices that allow users to inhale an aerosolized ''e-liquid" in lieu of traditional tobacco smoke. E-liquid typically contains varying compositions of propylene glycol (PG), vegetable glycerin (VG), flavorings, and/or nicotine. Since their introduction to the U.S. in 2007 [1] , e-cigs have experienced an exponential surge in popularity, with overall use increasing from 3.3% to 8.5% between 2010 and 2013 [2] , and usage among adolescents doubling between 2011 and 2012 alone [3] . E-cigs have gained traction not only among current smokers as a replacement or supplement to traditional cigarettes, but also among non-smokers who may not have otherwise developed smoking habits and nicotine addiction [4] . The rapid rise of e-cigs is often attributed to advertisements portraying e-cigs as a smoking cessation tool or as a completely safe alternative to traditional smoking. However, these claims have been widely found to be controversial and unfounded in scientific evidence [5, 6] .
Much remains to be elucidated about the health effects of e-cigs, as existing research is collectively inconclusive. Several studies have substantiated e-cig companies' claims of negligible e-cig toxicity, with a recent report finding only one e-cig brand marginally cytotoxic to mammalian fibroblasts, and still nearly eight times less potent than conventional cigarettes [7] . E-cigs have also been reported to contain toxicants at trace levels 9-450 times lower than in traditional cigarettes [8] and no toxicological synergies among their compounds [9] . However, numerous other studies suggest otherwise, concluding that e-cigs are hazardous and should be regulated similarly to traditional cigarettes [10] [11] [12] .
Heating of e-liquids to high temperatures has been found to release carcinogenic carbonyl compounds, such as formaldehyde, acetaldehyde, and acrolein [13] . The lungs have been shown to be especially vulnerable to e-cig exposure, as e-vapor particles deposit in lungs in a pattern similar to that of regular cigarette smoke particles [11] , producing changes in bronchial gene expression [10] and increased oxidative stress and inflammation [12] .
Among studies demonstrating the health risks of e-cigs, there is still a paucity of data regarding the cytotoxicity and genotoxicity of e-cig vapor and the role of e-liquid nicotine content in mediating the harmful effects of e-cig exposure. With e-cig usage becoming increasingly prevalent, it is critical to comprehensively evaluate the safety and potency of these devices. In this paper, we sought to investigate the cytotoxic and DNA strand break-inducing effects of nicotine-containing and non-nicotine-free e-cig vapor on a panel of epithelial cell lines. We also assess the contribution of e-cigs to the pathogenesis and progression of head and neck squamous cell carcinoma (HNSCC), a disease for which traditional cigarette smoking is a well-established risk factor yet the potential role of e-cigs has remained entirely unexplored.
Materials and methods

Cell culture
To explore the effects of e-cigs on the oropharynx, in vitro experiments were performed on normal epithelial cells as well as head and neck squamous cell carcinoma (HNSCC) cell lines. We chose to use the widely available cell line HaCat, a spontaneously transformed immortal keratinocyte, to determine the potential effects of e-cig on normal epithelium [14] . We also chose to use the HNSCC cell lines HN30 and UMSCC10B for two reasons. First, these cell lines were originally derived from the oropharynx, and second, we wanted to determine the potential effect of e-cigs on cancerous cell lines, to represent e-cig smokers that already have HNSCC. UMSCC10B was derived from a metastatic lymph node [15] . HN30 was derived from a primary laryngeal tumor [16] .
HaCaT, UMSCC10B, and HN30 were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 2% L-glutamine and 2% pen-strep. Media was replaced every three days, and cells were passaged at 90% confluence. All cells were cultured at 37°C and 5% CO 2 .
E-cigarette, cigarette, and nicotine treatments E-cigarette vapor was pulled through media using negative pressure, and the resulting extract was filter-sterilized with a 0.2 lm pore-size filter before treating cell cultures. The cigarettetreated media was made similarly using Marlboro Red filter cigarettes, which were determined by the Federal Trade Commission in a 2000 report to contain 1.2 mg of nicotine per cigarette. The e-cig brands V2 and VaporFi, two of the most popular e-cigarettes currently on the market, were chosen for our experiments. Both brands reportedly employ a standard mixture of 70% PG/30%VG liquid formula. For both V2 and VaporFi, we employed 1.2% nicotine e-liquid containing 12 mg of nicotine per mL, as well as the nicotine-free 0% nicotine versions in the same flavor, in order to investigate the properties of e-liquid independently of nicotine content. For VaporFi, the flavor ''Classic Tobacco" in Flavor Strength 1 was; for V2, the most similar flavor, ''Red American Tobacco," was used. For nicotine treatment, the calculated amount of nicotine hemisulfate salt solution (Cat # 65-30-5, Sigma-Aldrich, St Louis, MO) for the desired treatment concentration was directly added to the culture media.
Treatment media was replaced every three days with 1% e-cigarette extract. Because of the high toxicity of cigarette smoke extract, cigarette-treated samples of each cell line could only be treated for 24 h.
Neutral comet assay
HaCaT cells were treated for 8 weeks, and UMSCC10B and HN30 were each treated for a week. At the end of the treatment period, the cells were harvested, lysed, and underwent neutral electrophoresis (Trevigen). Comet tails were counted in multiple fields (>35 cells per sample) and analyzed using CometScore (TriTek Corp).
c-H2AX immunostaining
Cells were cultured on glass coverslips and treated for one week. Cells were then fixed, permeabilized, and stained with antibody to c-H2AX. Nuclei were stained with 4 0 6-diamidino-2-pheny lindole (DAPI). Foci were counted in 9-13 high-power fields per group using the program FociCounter (SourceForge).
Cell cycle analysis by flow cytometry
After one week of treatment, cells were trypsinized, harvested, and fixed with cold 50% (v/v) ethanol in PBS, and stored at À20°C for at least 24 h. The cells were then washed with PBS and resuspended with 80 lg/mL propidium iodide (PI) solution, and the DNA content was measured using flow cytometry.
Trypan blue staining
To evaluate the cytotoxic effects of e-cigarettes, cells treated for 48 h were trypsinized and the lifted cells resuspended in a 1:1 dilution of 0.4% trypan blue and PBS. The cells were incubated for five minutes at room temperature before visualizing under a light microscope and live and dead cells were counted using a hemacytometer.
Cell survival (clonogenic) assay
In clonal growth assays all populations were plated at 10 3 cells per 60 mm culture plate and cultured with media supplemented with 0.5% FBS. After 10-12 days of treatment, colonies were fixed with paraformaldehyde for 5 min, stained with crystal violet for 30 min, and counted. Colonies containing at least 30 cells were considered positive.
Annexin V apoptotic assay
Apoptotic cell death was analyzed using Annexin V-FITC Apoptosis Detection Kit, following the manufacturer's RAPID Annexin V Binding protocol (EMD Millipore, Cat # PF032). The assay was performed with two-color analysis of FITC-labeled Annexin V binding and PI uptake. Floating cells and adherent cells were counterstained with PI and analyzed by flow cytometry. Positioning of quadrants on Annexin V/PI dot plots was performed and live cells (Annexin VÀ/PIÀ, Q3), early/primary apoptotic cells (Annexin V+/ PIÀ, Q4), late/secondary apoptotic cells (Annexin V+/PI+, Q2) and necrotic cells (Annexin VÀ/PI+, Q1) were distinguished.
Statistical analysis
All statistical analysis performed and p values given were determined by Student's t-test. 
Results
E-cigarette vapor extract increases DNA damage via single-and double-strand breaks
One of the most pertinent questions regarding the relative safety of e-cigs is whether or not e-cigs have the potential to cause DNA damage in human cells. To evaluate the ability of e-cigs to induce DNA strand breaks, the normal human epithelial cell line HaCaT and two HNSCC cell lines UMSCC10B and HN30 were treated for one week with two brands of e-cigarette vapor at 1% by volume. Experiments were performed both in normal and cancer cells to assess the effects of e-cigs on healthy cells as well as existing HNSCC. Both the nicotine-free formula and formula containing 12 mg/mL nicotine were tested from each brand to determine if in vitro effects of e-cig vapor are consistent between different brands, and whether the effects are nicotine-dependent. For comparison, cells were also treated with conventional cigarette smoke or with 0.5 mM nicotine, with both nicotine concentrations equivalent to that of the treatment media for nicotine-containing e-cigs.
A neutral comet assay was performed on treated cells to evaluate the extent of DNA damage as determined by tail length (Fig. 1) . Our results show that e-cig vapor results in a statistically significant increase (up to 1.5-fold) in DNA strand breaks as compared to the untreated control. DNA damage is compounded in cells exposed to nicotine-containing e-cig vapor with these cells exhibiting a higher level of damage than cells treated with the equivalent concentration of nicotine alone. At the same time, we also show that DNA strand breaks are sufficiently induced even in the absence of nicotine, with cells exposed to nicotine-free e-cig vapor also exhibiting significant increases in DNA strand breaks relative to the untreated control.
Immunostaining for c-H2AX was then performed to specifically assess the formation of DNA double-strand breaks (DSBs), which are particularly dangerous to cells as they can lead to irreparable mutations and genomic aberrations. By quantifying the c-H2AX
foci count per cell, we determined that both V2 and VaporFi e-cig brands produced a significant induction of DSBs in HaCaT as compared to the untreated control, with foci number increased by up to 1.5-fold in nicotine-free e-cig-treated cells and up to 3-fold in nicotine-containing e-cig-treated cells (Fig. 2A) . We observed similar results in the HNSCC lines UMSCC10B and HN30, with cells exposed to V2 e-cig vapor exhibiting a significantly greater number of DSBs -up to 1.5-fold with nicotine-free e-cig and up to 2-fold with nicotine-containing e-cig (Fig. 2B ). Cells treated with cigarette smoke extract and nicotine at the same concentration of overall nicotine are shown for comparison. Cigarette smoke extract led to the highest number of DSBs in HaCaT and HN30 cell lines, but were not significantly higher than V2 nic 1%.
Cell lines treated with e-cigarette vapor extract show arrest in G1 and G2, and increased apoptosis and necrosis
To determine if e-cigarette exposure alters cell cycle profiles, UMSCC10B and HN30 treated with V2 and VaporFi e-cig vapor extract for one week were analyzed for DNA content by flow cytometry (Fig. 3 ). UMSCC10B showed a statistically significant increased accumulation of arrest in G1, and HN30 an increase in G2, both independently of e-cig nicotine content.
Next, to evaluate the extent and mechanisms of cell death resulting from e-cig vapor exposure, HaCaT cells were treated for one week with nicotine-containing and nicotine-free V2 and VaporFi e-cig vapor, and analyzed by flow cytometry using a conjugated Annexin V antibody and PI staining (Fig. 4) . This enabled differentiation among live, necrotic, early apoptotic, and late apoptotic cells. HaCaT cells were also treated with cigarette smoke extract and nicotine for comparison. HaCaT samples exposed to nicotine-free e-cig vapor extract showed a 53-68% increase in necrotic cells and a 120-200% increase in late/secondary apoptotic cells as compared to the untreated control, suggesting that e-cig Fig. 3 . HNSCC cell line exposure to e-cigarette vapor results in altered cell cycle profiles. UMSCC10B and HN30 were treated for one week at 1% by volume vaporized e-cigarette liquid with brands V2 and VaporFi, and analyzed by flow cytometry for DNA content. Results are given as mean percentage ± SEM. Peaks generated by flow cytometry analysis are shown for each of the permutations.
⁄ P < 0.05, ⁄⁄ P < 0.01, ⁄⁄⁄ P < 0.001.
vapor induces cell death both by necrosis and by apoptosis. HaCaT treated with nicotine-containing e-cig vapor extract exhibited a 20-134% increase in necrotic cells and a 121-258% increase in late/secondary apoptotic cells as compared to the control.
E-cigarette exposure results in increased cell death
For all cell lines, e-cig vapor exposure, independent of nicotine content, resulted in increased cell death as measured by trypan blue exclusion assay. HaCaT, UMSCC10B, and HN30 were treated for 48 h with 1% by volume V2 and VaporFi with and without nicotine prior to staining and counting (Fig. 5A) . Our results show that e-cig exposure induces a 5-fold increase in cell death without nicotine, and a 10-fold increase with nicotine as compared to the untreated control. Representative images of HaCaT treated at 2% by volume e-cig vapor for 2 weeks were taken at 200X bright field, showing significant cell death and changes in cell morphology as compared to the control (Fig. 5B ).
E-cigarette exposure decreases clonogenic survival
To evaluate the survival of normal and HNSCC cells with varying doses of e-cig vapor treatment, a clonogenic assay was performed using cells treated with 0.5%, 1.0%, and 2.0% by volume V2 and VaporFi e-cigarette vapor (Fig. 6A and B, respectively) . Cells treated with cigarette smoke extract and nicotine at 0.5 mM are shown for comparison. HaCaT cells were treated for 10 days, and UMSCC10B and HN30 for 12 days prior to colony enumeration. In UMSCC10B and HN30, 2% by volume vaporized e-cig treatment resulted in 100% cell death. Our results also show stepwise decrease in colony count and decreased survival with increasing e-cig doses in both brands independently of nicotine, with a greater than 2-fold decrease in survival in all cell lines after exposure to only 0.5% by volume nicotine-free e-cig vapor.
Discussion
Although e-cigs have skyrocketed in popularity and have been widely marketed as a safe alternative to traditional cigarettes, their safety and long-term effects have remained shrouded in controversy. In this paper, we have demonstrated cytotoxicity of shortterm e-cig vapor exposure on a panel of normal epithelial and HNSCC cell lines. Through Annexin V staining, trypan blue exclusion, and colony forming assays, we have shown that the cytotoxic effects of e-cig vapor are mediated through nicotine as well as nonnicotine components of the e-liquid. The specific substances in e-cig liquids are still under investigation, as many formulations are proprietary information. However, our findings are consistent with previous assessments of e-cig effects on pulmonary tissue and cell lines, which implicated flavoring compounds as primary toxicants within e-cigs [17] [18] [19] . Additionally, numerous studies have reported the presence of other hazardous substances in ecig vapor and heated e-liquid emissions, including the carcinogenic carbonyl compounds formaldehyde and acetaldehyde [8, 13, 20] , and oxidants and reactive oxygen species, heavy metals, and volatile organic compounds such as toluene [8, 21, 22] .
Because formaldehyde, acetaldehyde, and free radical species are well-known DNA damaging agents, especially in the context of conventional cigarette-associated diseases [25, 26] , we decided to assess the induction of DNA strand breaks in normal and HNSCC cell lines following both short-and long-term e-cig exposure. Our study is the first to conclusively link e-cigarettes to DNA breakage. Neutral comet assay and immunofluorescence staining for the DNA double-strand break (DSB) marker c-H2AX [27] revealed significantly increased tail length and c-H2AX foci numbers, respectively, in cells exposed to e-cig vapor, regardless of nicotine concentrations. Although the mechanism by which vaporized e-cig components induce strand breaks is still unclear, it is likely that ROS are implicated in the process. Lerner et al. demonstrated that the vaporization of e-cig liquids produced ROS which resulted in an inflammatory response in both human epithelial cells and mouse models [21] . More importantly, the presence of ROS is linked to single and double strand breaks, as well as oxidative DNA damage, as they modify nitrogenous bases by oxidation. The most common mutation is guanine oxidized to 8-oxo-7,8-dihydroguanine, which creates 8-oxo-deoxy guano sine (8-oxo-dG) [23] . The 8-oxo-dG is capable of base pairing with deoxyadenosine, instead of pairing correctly with deoxycytotidine, resulting in the replicated DNA containing a point mutation [24] .
The accumulation of DSBs in e-cig-treated cells is particularly suggestive of the carcinogenic potential of e-cigs. DSBs are predominantly repaired through the non-homologous end joining pathway, a notoriously error-prone process associated with the acquisition of genomic instability. Furthermore, the increased rates of G1 and G2 arrest we observed among cells exposed to e-cig suggest that higher-fidelity DSB repair mechanisms such as homologous recombination, which is primarily active in the S phase [28] , are even less utilized in e-cig-treated cells. While the maximum exposure period for our cell lines was two months, increased induction of DNA breakage was visible even after short-term (oneweek) e-cig treatment. Our findings therefore pose especially alarming implications for the genotoxic and carcinogenic effects of chronic e-cigarette use. Repeated introduction of DNA strand breaks due to long-term e-cig exposure, accompanied by successive rounds of dysfunctional DNA repair, would generate accumulated mutations and other genomic alterations in an inevitable progression toward cancer.
Moreover, given the immense variability of e-cig designs and usage habits, these potential health risks of e-cigarettes may even be understated. Regulation, quality control standards, and safety assessments for e-cig products have become further complicated by the rapid evolution of new e-cig devices and e-liquid formulations. These newer generations of e-cigs, in contrast to the ''firstgeneration" V2 and VaporFi brands used in our study, often boast larger batteries with adjustable voltages and a wider range of flavors, thus appealing more broadly to e-cig users [29] . Nextgeneration models have been shown to deliver greater doses of nicotine to users [30] , as well as higher levels of hazardous carbonyls and other toxins with increasing voltages [13, 20] . Meanwhile, an increasing number of users report customizing their e-liquids or introducing multi-wick heating coils and multichamber atomizers to their e-cig devices, typically to achieve stronger, more concentrated vapors [31] . Varied e-cig usage patterns, such as different puff durations or average ''vaping" session lengths, have also been associated with differential absorption of nicotine and e-cig vapor in users [32] . These recent trends in e-cig use and design combinatorially diversify the studies that must still be undertaken to accurately capture all health risks experienced by e-cig users. While focused safety assessments still remain elusive for most of the e-cig user demographic, our study nevertheless suggests that e-cigarettes should be viewed as far from risk-free or harmless in the interim.
Conclusion
In conclusion, our study strongly suggests that electronic cigarettes are not as safe as their marketing makes them appear to the public. Our in vitro experiments employing 2 brands of e-cigs show that at biologically relevant doses, vaporized e-cig liquids induce increased DNA strand breaks and cell death, and decreased clonogenic survival in both normal epithelial and HNSCC cell lines independently of nicotine content. Further research is needed to definitively determine the long-term effects of e-cig usage, as well as whether the DNA damage shown in our study as a result of e-cig exposure will lead to mutations that ultimately result in cancer. Fig. 6 . E-cigarette exposure decreases clonogenic survival in both normal and HNSCC cell lines. (A) HaCaT cells were treated for 10 days at 0.5%, 1.0%, and 2.0% by volume vaporized e-cigarette liquid. Colony counts were normalized to the untreated control cell cultures. Graphed results are given as mean colony count ± SEM. (B) and (C) the same treatments were replicated for 12 days using UMSCC10B and HN30 respectively. ⁄⁄⁄⁄ P < 0.0001.
